MedPath

Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway

Not Applicable
Active, not recruiting
Conditions
Intrauterine Growth Restriction
Pre-Eclampsia
Maternal Care for Known or Suspected Poor Fetal Growth
Interventions
Other: consecutive fetoneonatal healthcare pathway
Registration Number
NCT04514276
Lead Sponsor
Technische Universität Dresden
Brief Summary

Due to the fetoneonatal pathway it is possible to identify pregnant women with an increased risk of fetal growth restriction or pre-eclampsia in early stages (from 10th week of pregnancy). Women whose pregnancy is considered high-risk receives risk-adapted prenatal treatment as well as certain treatments for their newborn and infant until 1 year of age. The tasks of all involved persons are defined by standard operating procedures (SOP)

Detailed Description

By implementing a preventive feto-neonatal pathway, healthcare for pregnant women with high risk of fetal growth restriction (FGR) or pre-eclampsia will be improved and, therefore the occurence of children's health problems may be prevented.The pathway allows healthcare to be structured, ross-sectoral, inter- and multidisciplinary in consideration of medical and psychosocial imensions. The feto-neonatal pathway transfers scientific findings, which already determine international routine care, in the project region into clinical routine care. The anamnestically increased risk for FGR or pre-eclampsia is validated by ultrasound and the identified high-risk pregnancy is attended risk-adapted from birth until the end of the first year of life of the child.As a result, the mothers' pregnancy-related risks (death, premature delivery, traumatic stress disorders) as well as risks for the child (prematurity and associated problems, childhood growth restriction with the risk of metabolic syndrome, developmental neurological problems) are reduced and the sustainability of the interventions is ensured in the long term through improved health competence of the families. The feto-neonatal pathway shows how highly specialised fetoneonatal care of high-risk pregnancies can be ensured while ensuring primary care in a health region, and offers the possibility of being extended to other indications.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
828
Inclusion Criteria
  • Female, minim. 10 weeks of pregnancy, maximum 36 weeks of pregnancy
  • anamnestic risk of preeclempsia or fetal growth restriction
  • being part of the project region
Read More
Exclusion Criteria
  • none
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
consecutive fetoneonatal healthcareconsecutive fetoneonatal healthcare pathwayinclusion criteria: pregnant woman having higher risk of early fetal growth restriction, preeclempsia living in studyregion (east-Saxony or east Thuringia) the fetoneonatal pathway consists of four consecutive parts: (1) early perceiving of pregnant women with higher risks for early fetal growth restrictions via color Doppler sonography, fetal biometry, haemogram check (currently additional screenings) (2) structured care of the high risk women who are pregnant (3) concerted neonatal health care (4) adapted paediatric aftercare, certain dates and responsible persons are scheduled.
Primary Outcome Measures
NameTimeMethod
Evaluation of patients' safety: newborn's birthweight adjusted by gestational agethrough study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: maternal morbiditythrough study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: infantil morbiditythrough study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: Quality of lifethrough study completion, an average of 1 year and 7 months

Questionnaire: Quality of Life (Angermayer, Kilin \& Matschinger, 2000)

Evaluation of patient's access to treatment and satisfactionthrough study completion, an average of 1 year and 7 months

self-designed questionnaire

claim of the health servicesFrom admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

Evaluation of patients' safety: maternal pre-eclampsia ratethrough study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: attachment behaviorthrough study completion, an average of 1 year and 7 months

Questionnaire: Postpartum Bonding Questionnaire (Reck et al., 2006)

duration of unemployabilityFrom admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

prohibition of employmentFrom admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

Secondary Outcome Measures
NameTimeMethod
evaluation of ungoing processes during the fetoneontal health care pathway: effectiveness of fetoneonatal health careFrom admission to discharge, study inclusion to one year postpartum

based on secondary data provided by Health insurance funds

evaluation of ungoing processes during the fetoneontal health care pathway: the pathway's maintenance being long term part of routine health careFrom admission to discharge, study inclusion to one year postpartum

based on secondary data provided by Health insurance funds

evaluation of ungoing processes during the fetoneontal health care pathway: target patientsFrom admission to discharge, study inclusion to one year postpartum

based on secondary data provided by Health insurance funds

health economical evaluationFrom admission to discharge, study inclusion to one year postpartum

cost-benefit-analysis of patients' outcome in relation to supply costs based on secondary data provided by Health insurance funds

evaluation of ungoing processes during the fetoneontal health care pathway: implementation of participating employeesFrom admission to discharge, study inclusion to one year postpartum

based on secondary data provided by Health insurance funds

evaluation of ungoing processes during the fetoneontal health care pathway: participation of health care providerFrom admission to discharge, study inclusion to one year postpartum

based on secondary data provided by Health insurance funds

Trial Locations

Locations (2)

Universitätsklinikum Jena Klinik für Kinder- und Jugendmedizin

🇩🇪

Jena, Thuringia, Germany

Medizinische Fakultät Dresden Klinik und Poliklinik für Kinder- und Jugendmedizin / Neonatologie & Pädiatrische Intensivmedizin

🇩🇪

Dresden, Saxony, Germany

© Copyright 2025. All Rights Reserved by MedPath